Value Stocks To Watch Now - April 2nd

Market Beat
2025.04.04 20:05
portai
I'm PortAI, I can summarize articles.

ProShares UltraPro Short QQQ, CoreWeave, Inc. Class A Common Stock, and Intra-Cellular Therapies are highlighted as value stocks to watch according to MarketBeat. Value stocks are perceived to be undervalued based on fundamental analysis. ProShares UltraPro Short QQQ aims for three times the inverse of the NASDAQ-100 Index performance. CoreWeave focuses on AI infrastructure, while Intra-Cellular Therapies develops drugs for neuropsychiatric disorders. Each stock has shown significant trading volumes recently, indicating investor interest.

  • Bear Market Funds to Watch This Year

ProShares UltraPro Short QQQ, CoreWeave, Inc. Class A Common Stock, and Intra-Cellular Therapies are the three Value stocks to watch today, according to MarketBeat's stock screener tool. Value stocks are shares of companies that appear to be trading for less than their intrinsic value based on fundamental analysis, such as low price-to-earnings or price-to-book ratios. Investors in value stocks typically anticipate that the market will eventually recognize the company's true worth, leading to price appreciation over time. These companies had the highest dollar trading volume of any Value stocks within the last several days.

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

  • 7 best bear market ETFs to battle a decline

Shares of NASDAQ:SQQQ traded down $0.53 during mid-day trading on Wednesday, hitting $36.91. 86,376,573 shares of the company traded hands, compared to its average volume of 41,649,692. ProShares UltraPro Short QQQ has a 12-month low of $26.21 and a 12-month high of $64.95. The stock has a 50-day moving average price of $31.91 and a two-hundred day moving average price of $32.93.

Read Our Latest Research Report on SQQQ

CoreWeave, Inc. Class A Common Stock (CRWV)

  • Should You Bet Against The Nasdaq 100 With This Inverse ETF?

CoreWeave powers the creation and delivery of the intelligence that drives innovation. We are the AI Hyperscaler™ driving the AI revolution(1). Our CoreWeave Cloud Platform consists of our proprietary software and cloud services that deliver the software and software intelligence needed to manage complex AI infrastructure at scale.

NASDAQ CRWV traded up $2.09 on Wednesday, hitting $54.66. The stock had a trading volume of 40,251,100 shares, compared to its average volume of 30,987,895. CoreWeave, Inc. Class A Common Stock has a 52-week low of $36.00 and a 52-week high of $64.62.

Read Our Latest Research Report on CRWV

Intra-Cellular Therapies (ITCI)

Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that address medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms in the central nervous system (CNS) in the United States.

ITCI stock traded down $0.01 during midday trading on Wednesday, hitting $131.91. The stock had a trading volume of 16,042,154 shares, compared to its average volume of 1,460,295. Intra-Cellular Therapies has a 52-week low of $64.09 and a 52-week high of $131.98. The business has a 50-day moving average of $129.34 and a two-hundred day moving average of $100.60. The firm has a market cap of $14.05 billion, a price-to-earnings ratio of -151.62 and a beta of 0.69.

Read Our Latest Research Report on ITCI

Recommended Stories

  • MarketBeat's Top Five Stocks to Own in April 2025
  • Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
  • The 3 Most Talked About Investments on WallStreetBets Right Now
  • Analyst Targets Signal More Growth in CrowdStrike Stock
  • Why Howmet Could Be the Sleeper Aerospace Name of 2025
  • Will 2025 Be the Year the Energy Sector Finally Breaks Out?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in ProShares UltraPro Short QQQ Right Now?

Before you consider ProShares UltraPro Short QQQ, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProShares UltraPro Short QQQ wasn't on the list.

While ProShares UltraPro Short QQQ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Source: Market Beat The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer